Production & Manufacturing

The pharmaceutical manufacturing industry stands at a transformative inflection point. For decades, manufacturing processes operated based on established protocols perfected through empirical experience and regulatory validation. While effective, these traditional approaches rely heavily on retrospective quality assurance, periodic environmental...

Sterile pharmaceutical manufacturing represents one of the most technically demanding and highly regulated aspects of pharmaceutical production. The stakes are exceptionally high—any compromise in sterility assurance can render entire batches unusable or, worse, lead to contaminated products reaching patients...

The Australian-based biopharma company, CSL, plans to invest almost $1.5 billion in the next five years so as to expand its presence in the U.S. However, this is going to be subject to the approval from the board of...

The pharmaceutical manufacturing sector stands on the precipice of a fundamental digital transformation driven by the convergence of Internet of Things technologies, edge computing, artificial intelligence, and advanced analytics platforms. IoT in pharma manufacturing represents far more than simple...

The pharmaceutical industry faces an unprecedented convergence of pressures: escalating patient demand for complex biotherapeutics, environmental imperatives to minimize waste and energy consumption, and regulatory frameworks increasingly demanding advanced contamination control and process transparency. Sustainable sterile manufacturing has emerged...

The pharmaceutical and biotechnology industries are experiencing a profound technological revolution driven by CRISPR-Cas9 and emerging gene editing technologies that fundamentally alter how therapeutic agents are developed and manufactured. Gene editing pharma manufacturing represents far more than incremental improvement...

The pharmaceutical industry is experiencing a fundamental shift away from the traditional “blockbuster drug” model toward increasingly sophisticated precision medicine manufacturing strategies that prioritize individual patient needs over mass-market volume. This transformation represents far more than a simple adjustment...